Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells
出版年份 2020 全文链接
标题
Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells
作者
关键词
-
出版物
Epigenetics
Volume -, Issue -, Pages 1-18
出版商
Informa UK Limited
发表日期
2020-07-08
DOI
10.1080/15592294.2020.1789270
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New Spisulosine Derivative promotes robust autophagic response to cancer cells
- (2020) Asha Ganesher et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
- (2020) Ritika Tiwari et al. Nature Communications
- Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
- (2019) Maria Laura De Angelis et al. Frontiers in Oncology
- The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
- (2018) Xiaoli Huang et al. ACS Central Science
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
- (2018) Sara R. Martins-Neves et al. PHARMACOLOGICAL RESEARCH
- The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand
- (2017) Shan-zhong Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A–β-Catenin Signaling and Restricts Tumor Growth and Metastasis
- (2017) Shrankhla Maheshwari et al. MOLECULAR CANCER THERAPEUTICS
- Salinomycin kills cancer stem cells by sequestering iron in lysosomes
- (2017) Trang Thi Mai et al. Nature Chemistry
- Salinomycin: A new paradigm in cancer therapy
- (2017) Jayant Dewangan et al. TUMOR BIOLOGY
- Salinomycin simultaneously induces apoptosis and autophagy through generation of reactive oxygen species in osteosarcoma U2OS cells
- (2016) Sang-Hun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer
- (2016) Anup Kumar Singh et al. CARCINOGENESIS
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Cancer stem cell drugs target K-ras signaling in a stemness context
- (2016) A K Najumudeen et al. ONCOGENE
- Survival of skin cancer stem cells requires the Ezh2 polycomb group protein
- (2015) Gautam Adhikary et al. CARCINOGENESIS
- Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling
- (2015) Ying Lu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis
- (2015) Rakesh K. Arya et al. Scientific Reports
- ER-Stress-Induced Differentiation Sensitizes Colon Cancer Stem Cells to Chemotherapy
- (2015) Mattheus C.B. Wielenga et al. Cell Reports
- Tumor heterogeneity and cancer stem cell paradigm: Updates in concept, controversies and clinical relevance
- (2014) Anup Kumar Singh et al. INTERNATIONAL JOURNAL OF CANCER
- Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice
- (2014) Wolfgang Boehmerle et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- EZH2: Not EZHY (Easy) to Deal
- (2014) Gauri Deb et al. MOLECULAR CANCER RESEARCH
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
- (2014) Hariharan Easwaran et al. MOLECULAR CELL
- Salinomycin Potentiates the Cytotoxic Effects of TRAIL on Glioblastoma Cell Lines
- (2014) Alessia Calzolari et al. PLoS One
- Epithelial-to-Mesenchymal Transition Activates PERK-eIF2 and Sensitizes Cells to Endoplasmic Reticulum Stress
- (2014) Y.-x. Feng et al. Cancer Discovery
- Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: Differences between primary and cancer cells
- (2013) Jaganmohan Reddy Jangamreddy et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- ER Stress Causes Rapid Loss of Intestinal Epithelial Stemness through Activation of the Unfolded Protein Response
- (2013) Jarom Heijmans et al. Cell Reports
- A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis
- (2012) M.-A. Dillies et al. BRIEFINGS IN BIOINFORMATICS
- Understanding cancer stem cell heterogeneity and plasticity
- (2012) Dean G Tang CELL RESEARCH
- Salinomycin as a Drug for Targeting Human Cancer Stem Cells
- (2012) Cord Naujokat et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells
- (2012) Yannick D. Benoit et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epigenetic alterations involved in cancer stem cell reprogramming
- (2012) Purificación Muñoz et al. Molecular Oncology
- Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species
- (2012) Berlinda Verdoodt et al. PLoS One
- EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter
- (2012) Lilian E. van Vlerken et al. Stem Cells Translational Medicine
- Salinomycin can effectively kill ALDHhigh stem-like cells on gastric cancer
- (2011) Qiao Ming Zhi et al. BIOMEDICINE & PHARMACOTHERAPY
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
- (2011) Piyush B. Gupta et al. CELL
- Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis
- (2011) Melisa A. Martínez-Paniagua et al. CELL CYCLE
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
- (2011) Desheng Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endoplasmic-Reticulum Calcium Depletion and Disease
- (2011) D. Mekahli et al. Cold Spring Harbor Perspectives in Biology
- Salinomycin induces calpain and cytochrome c-mediated neuronal cell death
- (2011) W Boehmerle et al. Cell Death & Disease
- Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
- (2010) Sha Hu et al. CANCER BIOLOGY & THERAPY
- The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer
- (2010) J Yu et al. ONCOGENE
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Epigenetic Silencing of Death Receptor 4 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Gliomas
- (2009) A. Elias et al. CLINICAL CANCER RESEARCH
- TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
- (2008) Y. Zhang et al. MOLECULAR CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started